HUMIRA® (adalimumab) for Plaque Psoriasis (PS)
HUMIRA is a prescription medicine used to treat adults with moderate to severe chronic plaque psoriasis (Ps) who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate.
Humira for plaque psoriasis: Dosage, how it works, and more
Mar 19, 2022 · New or worsening psoriasis can be a serious side effect of Humira. But Humira has been shown in clinical studies to be an effective treatment for moderate to severe plaque psoriasis...
HUMIRA® (adalimumab) and plaque psoriasis
Plaque Psoriasis: HUMIRA is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HUMIRA should only be administered to patients who will be closely monitored and have regular follow ...
Treating Psoriasis and Psoriatic Arthritis with Humira
Humira is a biologic approved for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, Crohn's disease, and rheumatoid arthritis.
Humira: Uses, Dosage, Side Effects, Warnings - Drugs.com
Dec 11, 2024 · Humira is used to treat many inflammatory conditions in adults, such as rheumatoid arthritis (RA), psoriatic arthritis (PA), ankylosing spondylitis (AS), plaque psoriasis, and a skin condition called hidradenitis suppurativa.
11 Biologic Medications for Psoriasis Treatment - WebMD
Jun 9, 2023 · These drugs are called biologics. They target a specific part of your immune system. The drugs block certain cells or proteins that play a role in psoriasis. They keep them from going into...
Adalimumab for psoriasis - DermNet
The original brand of adalimumab has the trade name Humira®. Generic biosimilar adalimumab is also marketed in several countries. How effective is adalimumab in psoriasis? Adalimumab has been studied in several thousand adult patients with moderate to severe psoriasis.
Adalimumab for Adult Patients with Plaque Psoriasis: A Review ...
Jun 10, 2020 · Biologics approved for patients with moderate-to-severe plaque psoriasis include of TNF-α inhibitors (e.g., as adalimumab and infliximab), IL-17 inhibitors (e.g., ixekizumab, and secukinumab) and IL-23 inhibitors (e.g., risankizumab). 3,4,6–9 Unlike the non-specific conventional immunomodulators, biologic treatments for psoriasis are less likely...
Humira can be prescribed to treat severe plaque psoriasis in adults and children over the age of four. Usually it will only be offered to people who have not responded to, or cannot take non-biologic systemic treatments including ciclosporin, methotrexate or PUVA light therapy.
Adalimumab: Uses, Dosage, Side Effects, Warnings - Drugs.com
Dec 10, 2024 · Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid arthritis, and other chronic autoimmune conditions. Compare Humira and available biosimilars.
- Some results have been removed